Maravai Lifesciences Holdings
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $49,866 | $41,630 | $47,397 | $46,850 |
Gross Profit | 12,242 | 5,655 | 7,768 | 7,725 |
EBITDA | -41,721 | -22,463 | -51,924 | -31,003 |
EBIT | -56,454 | -38,305 | -67,310 | -45,913 |
Net Income | -35,681 | -25,556 | -39,591 | -29,945 |
Net Change In Cash | 49,866 | 41,630 | 47,397 | 46,850 |
Free Cash Flow | -24,882 | -18,076 | -13,139 | -14,625 |
Cash | 216,890 | 243,574 | 269,907 | 285,053 |
Basic Shares | 145,074 | 144,683 | 144,236 | 143,425 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $185,743 | $259,185 | $288,945 | $883,001 |
Gross Profit | 33,390 | 108,309 | 140,202 | 714,044 |
EBITDA | -147,111 | -156,917 | 712,409 | 609,989 |
EBIT | -207,982 | -213,782 | 663,628 | 571,886 |
Net Income | -130,773 | -144,846 | -119,029 | 220,205 |
Net Change In Cash | 185,743 | 259,185 | 288,945 | 883,001 |
Free Cash Flow | -70,722 | -22,193 | 60,671 | 518,887 |
Cash | 216,890 | 322,399 | 574,962 | 632,138 |
Basic Shares | 145,074 | 137,906 | 131,919 | 131,695 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.04 |
2025-09-30 | -$0.08 |
2025-06-30 | -$0.08 |
